ArticleNature materials2026
Bioresorbable metal-free molecular magnets enable untethered organ monitoring.
Article in Nature materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-free molecular magnets differ from conventional magnetic devices that predominantly rely on metallic magnets as these metal-free materials may offer biocompatibility and bioresorbability. However, existing molecular materials lack the ferromagnetic strength required for high-fidelity sensing at clinically relevant tissue depths. Here we introduce a bioresorbable metal-free molecular magnet derived from graphitic carbon nitride, combining metallic-level ferromagnetism with full bioresorbability. De-nitrogenation creates spin centres coupled through a reconstructed π-σ conjugated framework, conferring robust spontaneous magnetization that remains stable under physiological conditions. Integrated with poly(lactic-co-glycolic acid) and silk fibroin, the material forms catheter-deliverable epicardial patches for cardiac tracking and can also be dispersed in injectable hydrogels for organ-scale sensing, including the three-dimensional reconstruction of localized hepatic pathologies. Coupled with a skin-interfaced Hall array, this magnetic sensing architecture provides the continuous, untethered monitoring of multi-organ dynamics, robust against motion artifacts and tissue impedance. In porcine models, it facilitates the continuous assessment of ejection fraction over 4 weeks, followed by benign bioresorption. Benchmarked against standard-of-care echocardiography, this approach delivers clinical-grade trajectories, supporting longitudinal, infrastructure-independent physiological monitoring.
Identifiers
42897210What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.